ÂÜÀòÂÒÂ×

Chunlin Chen began their work experience as the Director of Parker Hughes Institute in July 1997, where they held this position until January 2002. Chunlin then joined Vertex Pharmaceuticals in February 2002 as a Staff Investigator, and worked there until January 2004. In February 2004, Chunlin became the CEO of Shanghai Medicilon Inc., where they currently hold this position.

Chunlin Chen began their education journey in 1991 at Oklahoma State University where they pursued a Ph.D. in Pharmacology and Toxicology. They successfully completed their doctoral degree in 1994. Following this, Chunlin Chen proceeded to St Jude Children's Research Hospital, where they served as a Postdoctoral Fellow in Pharmaceutical Sciences from 1994 to 1997.